AVENUE THERAPTC Cash Flow - Annual (NASDAQ:ATXI)

Add to My Stocks
$3.27 $0.26 (7.37%) ATXI stock closing price Sep 19, 2018 (Closing)

The AVENUE THERAPTC cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For AVENUE THERAPTC profits one has to check the income statement and for AVENUE THERAPTC debt one has to check the balance sheet. AVENUE THERAPTC cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. AVENUE THERAPTC had cash and cash equivalents of $- at the beginning of the year and $11.78M at year end for 2017. AVENUE THERAPTC had an outflow of $-6.8M from operating activities, $28.38M inflow due to financing activities, and $-10M outflow due to investing activities for 2017.

View details of AVENUE THERAPTC cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec201720162015
Net Income Cash Flow
-12.25M-3.17M-
Depreciation Depletion Amortization Cash-Flow---
Net Increase (Decrease) in Assets Liabilities2.07M1.08M-
Cash From (used in) Discontinued Operations---
Other Adjustments Net3.2M--
Net Cash from (used by) Operating Activities
-6.8M-1.63M-
Increase (Decrease) in Prop Plant And Equipment---
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments-10M--
Other Cash Inflow (Outflow) from Investment Activities---
Net Cash from (used by) Investment Activities
-10M--
Issuance (Purchase) of Equity Shares37.95M--
Issuance (Repayment) of Debt Securities-3M--
Increase (Decrease) in Bank & Other Borrowings-2.84M1.67M-
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities-3.71M-0.05M-
Net Cash from (used by) Financing Activities
28.38M1.81M-
Effect of Exchange Rate Changes on Cash---
Net Change in Cash & Cash Equivalents
11.58M--
Cash & Equivalents at Beginning of Year---
Cash & Equivalents at Year End11.78M--
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The AVENUE THERAPTC stock price history and AVENUE THERAPTC stock comparison chart inevitably reflect its cash flow situation.

  • AVENUE THERAPTC had a Net Change in Cash and Cash Equivalents of $11.58M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the AVENUE THERAPTC stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. AVENUE THERAPTC lost $-6.8M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-10M for ATXI stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $28.38M for AVENUE THERAPTC.

Key Financial Ratios For AVENUE THERAPTC Cash Flow

Annual Cash Flow Statements For AVENUE THERAPTC Peers

AIT THERAPEUTIC cash flow, Biomerica cash flow, Lipocine cash flow, ProPhase Labs cash flow